Journal: eLife
Article Title: Netrin signaling mediates survival of dormant epithelial ovarian cancer cells
doi: 10.7554/eLife.91766
Figure Lengend Snippet: ( A ) Illustration of netrin ligands, receptors, and other intracellular signaling molecules that are included in the Axon Guidance pathway category. The frequency of their identification in CRISPR screens is illustrated by shading and indicates how many cell lines had an enrichment ratio <1 for a given component. ( B ) The indicated ovarian cancer cell lines were infected with lentiviruses expressing sgRNAs directed against the indicated Netrin signaling genes. Cells were transferred to suspension culture conditions to induce spheroid formation for 72 hr and then returned to adherent conditions for 24 hr to facilitate reattachment. Re-attached cells were stained with Crystal Violet and retained dye was extracted and quantitated to measure relative survival. Each cell-gene combination was assayed in at least three biological replicates, averaged, and viability is displayed as a bubble plot. Mean survival for a given cell-gene combination was compared with GFP control gRNA transduced cells using one way anova and significance levels are illustrated by bubble size. Inviable cell-gene combinations are depicted as empty spaces. ( C ) Cultures of the indicated cell lines were cultured in suspension for five days and stimulated with 0.5 μg/mL Netrin-1. Netrin-1 signaling was analyzed by SDS-PAGE and western blotting for phospho-ERK, ERK, and tubulin. ( D ) Quiescent adherent OVCAR8 cells were stimulated with 0.5 μg/mL Netrin-1 or 0.5 μg/mL EGF, and compared with OVCAR8 cells in suspension stimulated as in C. Extracts were prepared and blotted for phospho-ERK, ERK, and tubulin. ( E ) Suspension cultures of OVCAR8, or knock out derivatives, were harvested and analyzed for relative phosphorylation levels of ERK by western blotting. Total ERK and tubulin blotting serve as expression and loading controls. ( F ) Netrin-1 signaling in OVCAR8, UNC5 4KO and DDN 3KO derivatives was tested by transferring cells to suspension and stimulating with Netrin-1 as before. Western blotting for phospho-ERK, ERK were also as before. ( G ) OVCAR8 cells were seeded in suspension culture and treated with the MEK inhibitors PD184352, Trametinib or DMSO vehicle for 72 hr. Mean viability was determined by re-attachment and compared by one way anova (****p<0.0001). ( H ) OVCAR8 cells were cultured in suspension and treated with Trametinib or DMSO vehicle as in G. Viability was determined by trypan blue dye exclusion and compared by one way anova (**p<0.01). ( I ) Extracts were prepared from Trametinib and control treated spheroid cells and blotted for phospho-ERK, ERK, and tubulin. ( J ) Model summarizing the roles of Netrin ligands, receptors, and downstream targets MEK and ERK in dormant survival signaling. Figure 5—source data 1. Numerical data used for bubble plot in . Figure 5—source data 2. Original files for western blot analysis in (pERK T202/Y204, ERK, Tubulin). Figure 5—source data 3. PDFs containing annotation of original western blots in (pERK T202/Y204, ERK, Tubulin). Figure 5—source data 4. Original files for western blot analysis in (pERK T202/Y204, ERK, Tubulin). Figure 5—source data 5. PDFs containing annotation of original western blots in (pERK T202/Y204, ERK, Tubulin). Figure 5—source data 6. Original files for western blot analysis in (pERK T202/Y204, ERK, Tubulin). Figure 5—source data 7. PDFs containing annotation of original western blots in (pERK T202/Y204, ERK, Tubulin). Figure 5—source data 8. Original files for western blot analysis in (pERK T202/Y204, ERK). Figure 5—source data 9. PDFs containing annotation of original western blots in (pERK T202/Y204, ERK). Figure 5—source data 10. Numerical data used for graphs in . Figure 5—source data 11. Original files for western blot analysis in (pERK T202/Y204, ERK, Tubulin). Figure 5—source data 12. PDFs containing annotation of original western blots in (pERK T202/Y204, ERK, Tubulin).
Article Snippet: Antibodies used for blotting were p42/44 MAPK (Erk1/2) (Cell Signaling Technology rabbit antibody #4695), Phospho-p44/42 MAPK(Erk1/2) T202/Y204 (Cell Signaling Technology; rabbit antibody #4370), p38 MAPK (Cell Signaling Technology; rabbit antibody #9212), p38 MAPK T180/Y182 (Cell Signaling Technology; rabbit antibody #9211), p130(RBL2, Santa Cruz Biotechnology, rabbit antibody sc-317 discontinued), Ki67 (Abcam rabbit antibody, # ab16667), DYRK1A (Cell Signaling Technology anti-DYRK1A rabbit antibody #8765), Netrin-1 (Abcam rabbit antibody #ab126729), Netrin-3 (Abcam rabbit antibody #ab185200), α-tubulin (Cell Signaling Technology anti-αTubulin rabbit antibody #2125) and β-actin (Millipore Sigma rabbit antibody #A2066).
Techniques: CRISPR, Infection, Expressing, Suspension, Staining, Control, Cell Culture, SDS Page, Western Blot, Knock-Out, Transferring